Article Details

China NMPA recommends priority review for Everest's IgA nephropathy therapy

Retrieved on: 2023-01-02 08:19:42

Tags for this article:

Click the tags to see associated articles and topics

China NMPA recommends priority review for Everest's IgA nephropathy therapy. View article details on HISWAI: https://www.pharmaceutical-technology.com/news/china-everest-iga-nephropathy/

Excerpt

The China National Medical Products Administration's (NMPA) Center for Drug Evaluation (CDE) has recommended priority review for Everest ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up